ProPhase Labs, Inc.
PRPH- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000868278
No open-market purchases or sales by ProPhase Labs, Inc. insiders were filed in the last 90 days; 2 institutions reported holding it in 13F filings for Q2 2026, worth $2 in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding ProPhase Labs, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 39 | 43 | +4 |
| Shares | 1.96M | 2.69M | +725.0K (+37.0%) |
| Value | $24.9M | $30.3M | +$5.41M (+21.7%) |
New holders (10)
Institutions that held ProPhase Labs, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Invesco Ltd. | 129,215 | $1.46M | 0.00% |
| American Century Companies Inc | 48,896 | $552.0K | 0.00% |
| O'Shaughnessy Asset Management, LLC | 40,853 | $461.0K | 0.01% |
| Navellier & Associates Inc | 40,219 | $454.0K | 0.10% |
| First Trust Advisors LP | 34,101 | $385.0K | 0.00% |
| Ritholtz Wealth Management | 20,676 | $233.0K | 0.01% |
| Keebeck Wealth Management, LLC | 20,000 | $226.0K | 0.04% |
| Bailard, Inc. | 11,200 | $126.0K | 0.01% |
| Occudo Quantitative Strategies LP | 11,158 | $126.0K | 0.01% |
| Covestor Ltd | 3,316 | $37.0K | 0.03% |
Sold out (6)
Institutions that held ProPhase Labs, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Virtu Financial LLC | 34,275 | $435.0K |
| Goldman Sachs Group Inc | 12,905 | $164.0K |
| Captrust Financial Advisors | 1,000 | $13.0K |
| Citigroup Inc | 720 | $9.00K |
| CoreCap Advisors, LLC | 100 | $1.00K |
| FMR LLC | 1 | $0 |